Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation TCT India 2025

How do we predict risk in complex/high-risk PCI? Using scores and paradigms effectively

Presenter: Sundeep Mishra

July 27, 2025

Presentation TCT India 2025

Addressing delays in Reperfusion – CPC - A new initiative from STEMI

Presenter: Thomas Alexander

July 26, 2025

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Jacob Eifer Møller

April 07, 2024

Presentation Miami Valves 2024

Contemporary management of AMI Shock in the Cath Lab – Evidence based Clinical Case?

Presenter: Carlos D. Davila

February 03, 2024

Presentation EuroPCR 2023

Poor outcomes in occlusive ACS patients presenting without ST-elevation

Presenter: Robert Herman

May 19, 2023

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

Presentation TCT 2020

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Presenter: Byeong-Keuk Kim

October 14, 2020

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation

Association Between Cath Lab Activation and Reperfusion/Outcomes in STEMI

September 18, 2018

Presentation TCT 2014

Impact of Hospital vs_ Home call for Fellows and Cath Lab Team on Door to Balloon Times

Presenter: Luke Kohan

September 16, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Presenter: Luigi Salemme, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Presentation

Performance of a New ‘Physician-Less’ Automated System of Prehospital STEMI Diagnosis and Cath Lab Activation

Presenter: B.J. Potter

April 29, 2013

Presentation TCT 2012

False Activations of the Cath Lab: New Insights and Recommendations

Presenter: Gary Schaer

October 26, 2012

Advertisement

How do we predict risk in complex/high-risk PCI? Using scores and paradigms effectively

Addressing delays in Reperfusion – CPC - A new initiative from STEMI

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Contemporary management of AMI Shock in the Cath Lab – Evidence based Clinical Case?

Poor outcomes in occlusive ACS patients presenting without ST-elevation

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Association Between Cath Lab Activation and Reperfusion/Outcomes in STEMI

Impact of Hospital vs_ Home call for Fellows and Cath Lab Team on Door to Balloon Times

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Are GP IIb/IIIa Inhibitors Still Useful?

Performance of a New ‘Physician-Less’ Automated System of Prehospital STEMI Diagnosis and Cath Lab Activation

False Activations of the Cath Lab: New Insights and Recommendations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content